From October 19 to 21, Factor-h organized in Barranquilla, Colombia, the 2022 Huntington Latin American Conference with the presence of 35 speakers among them scientists, researchers, experts in different health fields, HD associations, patients, and families. In his Welcome conference on the 19th, Factor-h’s President and founder, neuroscientist Ignacio Muñoz Sanjuan, presented the guidelines and achievements of the non-profit organization.
![](https://factor-h.org/wp-content/uploads/2024/07/Screenshot-2024-07-10-at-14.20.40-300x168.png)
Factor-H
Uniqure’s AMT-130 Phase 1/2 trial – a reflection
Yesterday, Uniqure reported on the 24-month results of their Phase 1/2 clinical trial with AMT-130, a viral gene therapy trial
One Response
Contundente mensaje de Factor H a nosotros Neurólogos, sensores fundamentales de la problemática dé atención integral a los pacientes, grupos y cuidadores, puentes para la consciencia de la atencion primaria y la gobernanza.